-
Qilu Pharmaceutical once again qualified and firstly submitted the application for olaparib generic drug listing
Time of Update: 2021-11-11
In China, the original research olaparib was approved by the NMPA in December 2018 for the maintenance treatment of platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer in adult patients after platinum-containing chemotherapy has achieved complete remission or partial remission , The trade name is Lipzo .
-
Scientists uncover the frontier secrets of cancer immunotherapy
Time of Update: 2021-11-11
Scientists uncover the frontier secrets of cancer immunotherapy Scientists uncover the frontier mystery of cancer immunotherapyScientists uncover the frontier mystery of cancer immu
-
On the 27th, 39 new cases were diagnosed with new crowns, including 23 in the local area
Time of Update: 2021-11-11
As of 24:00 on October 27, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 659 confirmed cases (including 33 severe cases), a total of 91,643 cured and discharged cases, and a total of 4,636 deaths.
-
A total of 247,472,724 confirmed cases of new crowns worldwide
Time of Update: 2021-11-11
Reached 5012337 cases .
-
New technology creates new targets for RNA therapy
Time of Update: 2021-11-11
Genetically modified Because transgenes are dangerous when expressed in the wrong cells, scientists have been hoping to find a way to reduce the off-target effects of gene therapy .
-
The First Affiliated Hospital of the University of Science and Technology of China has made important progress in the field of CT imaging research
Time of Update: 2021-11-11
Significant progress in spectral CT imaging research: A stable, reliable, accurate and fast cone-beam CT image reconstruction algorithm is proposed, which solves the problem of cone-beam CT image artifacts, the accuracy of radiation dose calculation for radiotherapy, and tumor lesions and soft tissue organs The recognizability of both has been greatly improved .
-
CDE publicly solicits ICH E14, Q&A and Q3C (R8) guidelines for implementation suggestions
Time of Update: 2021-11-11
On November 2, the CDE official website issued an announcement stating that in order to do a good job in the implementation of the ICH guidelines, the center drafted the ICH "E14 and Questions and Answers: Non-antiarrhythmic drugs cause QT/QTc interval prolongation and potential arrhythmic effects.
-
Research proves that heat exposure may increase the risk of heart, kidney, and psychiatric diseases
Time of Update: 2021-11-11
The reporter learned on the 29th that an international team led by Professor Tong Shilu from the Clinical Epidemiology and Biostatistics Laboratory of the Shanghai Children’s Medical Center affiliated to Shanghai Jiaotong University School of Medicine and the National Children’s Medical Center (Shanghai) found that the health hazards caused by heat exposure are harmful to urban residents.
-
Notice on the publication of the contact information (third edition) of the "variety guardian" of the pharmaceutical excipient standard in the "Chinese Pharmacopoeia"
Time of Update: 2021-11-11
Recently, due to changes in the contact numbers and email addresses of some of the "variety guardians", our committee has issued the "Chinese Pharmacopoeia" medicinal excipient standard "variety guardians" contact information (third edition), see the attachment .
cn Appendix: The contact information of the "Variety Guardian" in the "Chinese Pharmacopoeia" pharmaceutical excipient standard (third edition).
-
Chinese scientists elected as foreign academicians of the Russian Academy of Natural Sciences
Time of Update: 2021-11-11
The Russian Academy of Natural Sciences is composed of outstanding scientists and experts who have made major achievements in the fields of natural sciences and humanities, and has important academic influence .
Foreign academicians include Distinguished scientists from 48 countries around the world .
-
The popular varieties of injection collection are about to start fighting
Time of Update: 2021-11-11
7. Voriconazole for injection: There are currently 4 domestic approvals with 4 batch numbers, the original research is Pfizer, there are 22 acceptance numbers for generic drug registration applications for category 4, and one application for consistency evaluation is Sichuan Meidakang Huakang Pharmaceutical.
-
Titanium dioxide is classified as a second-class carcinogen, and EMA issued a statement on alternative materials for tablet coatings and capsule shells!
Time of Update: 2021-11-11
The direct and indirect impacts on medicines for human and veterinary use are expected to be aggravated in the scenario, where Europe would be the onlyregion globally to ban TiO2 as excipient in medicines, which would requireindustry to develop new formulations for the majority of oral solid doseproducts potentially for the EU only, with titanium dioxide continuing to beused in the majority of medicines globally.
-
CDE issued the "Management Regulations for the Suspension and Resumption of Review Timings in the Drug Review Process of the State Drug Administration" (Draft)!
Time of Update: 2021-11-11
Chapter 2 Specific Operations for Suspension and Resumption of Timekeeping Article 7 (Details of disapproval of publicity) Circumstances of " disapproval of publicity and handling of objections to review conclusions ": If the review conclusion is not passed , the Center for Drug Evaluation shall notify the applicant through the "Applicant Window" 15 days before the expiration of the review time limit, and the time will be automatically suspended .
-
Tan Desai warns of the emergence of a new virus beyond human control
Time of Update: 2021-11-11
According to a report from the Russian Satellite Network on the 30th, the Director-General of the World Health Organization Tan Desai warned that a new virus that cannot be controlled by humans may appear "at some time" and pointed out that it is necessary to strengthen the world.
-
The domestic CAR-T price is released for the first time!
Time of Update: 2021-11-11
Innovative medicine and medical insurance negotiations attract attention In addition to CAR-T therapy, Guangdong also announced the proposed online prices of several innovative drugs this time.
-
115 supplementary drugs will be transferred out of Shandong Medical Insurance
Time of Update: 2021-11-11
Zhejiang: 118 provinces add supplementary medicines On August 3, 2021, the Zhejiang Provincial Medical Insurance Bureau and the Zhejiang Provincial Department of Human Resources and Social Security issued the "Notice Regarding the Transfer of Certain Medicines from the Zhejiang Provincial Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Lists", starting from January 1, 2022, 118 drugs including amoxicillin and dicloxacillin were transferred out of the Zhejiang Medical Insurance List .
-
Message from Zhong Nanshan on Medical Education: Focus on Cultivating the Spirit of Innovation
Time of Update: 2021-11-11
He hoped that the education of the medical school should be "health-centered" instead of "treatment-centered", so as to achieve early detection, early diagnosis and early treatment of chronic diseases .
-
Stem cells help gecko regenerate "perfect" tail
Time of Update: 2021-11-11
The results showed that the tails grown from these modified stem cells had bone-like grooves in the cartilage, and new nerve tissue was formed on the top of the tail .
-
Over 2 billion "magic medicine" fell!
Time of Update: 2021-11-11
TOP3 products of terminal anti-gout preparations in Chinese public medical institutions Source: Mi Nei. com, China's public medical institutions terminal competition pattern Before centralized procurement, febuxostat had a strong tendency to monopolize the market .
-
There are still antibodies in the body 10 months after being infected with the new crown
Time of Update: 2021-11-11
The latest results show that there are differences in the spike proteins of the alpha, beta, and delta mutant strains of the new coronavirus, which means that a vaccine designed around one of the mutant strains may be less effective on other mutant strains .
